Oncopeptides AB (publ) 8,40
Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden. Læs mere
Kr. 633M Markedsværdi
Kr. 118M Omsætning
Bioteknologi Industri
Sverige Hjemland
Sundhed Sektor